Oymotion Secures Nearly RMB 100 Million in Series B++ Funding to Accelerate Global Expansion and Next-Gen Robotic Hand Development

This round of financing will inject strong momentum into OYMotion, assisting the company in achieving leapfrog development in multiple key areas. The funds will be mainly used to accelerate continuous R&D breakthroughs in the dexterous hand technology field, promote the launch process of a new generation of dexterous hand products, and expedite the market entry of finger joint exoskeleton robots. Meanwhile,Establish an internationally leading standardized production system, optimize production processes, and achieve a 100% increase in annual production capacity.In addition, OYMotion will further advance its global market layout, providing higher quality and more efficient solutions to customers worldwide.

In 2015, OYMotion was officially established in Shanghai's Zhangjiang High-Tech Park.As one of the few innovative companies in China that simultaneously master the two core underlying technologies of brain-computer interface and robotics, OYMotion Technology Co., Ltd. always focuses on the cross-integration of brain science and robotics technology.Successfully built a "neural interface-robot-AI algorithm"三位一体 self-developed platformAfter nearly a decade of technical沉淀, OYMotion has developed multiple innovative products that combine technological leadership with commercial feasibility, and their performance and cost-effectiveness have gained widespread recognition in the global market.

In the cutting-edge field of embodied robotics, the first dexterous hand product launched by OYMotion has already served multiple clients in the main body robot sector and received widespread acclaim. On one hand, as one of the most crucial upstream solutions for main body robots, the dexterous hand has always been highly anticipated within the industry. On the other hand, as a representative product of precision intelligent manufacturing, the dexterous hand faces high technical barriers, complex craftsmanship challenges, and stringent system requirements. Therefore, in the dexterous hand industry, there has always been an "impossible triangle"—the difficulty of balancing the three aspects of "cost, system parameters, and system stability."

OYMotion is the earliest team in China that has focused on the research of hand-shaped robots. Since 2017, it has completed dozens of iterations and successfully promoted the implementation of hand-shaped robots in various scenarios, such as smart bionic hands integrated with neural interfaces (EMG) for amputees, multiple dexterous hand products for embodied intelligence customers, and finger joint exoskeleton robot products for people with hand dysfunction.

As one of the few manufacturers in the market with both mass production experience and batch delivery capabilities, OYMotion has achieved the impossible triangle by building multi-scenario SKUs, becoming a key player in the first tier of dexterous hand technology. Currently, OYMotion is continuously focusing on product innovation. The new generation of dexterous hand, ROH-AP001, will have sensing abilities such as touch and pressure, and is expected to be officially launched in the market soon.

In the field of brain science, OYMotion has developed a medical-grade neuro-interaction software and hardware integrated infrastructure platform based on its self-developed brain/muscle-computer interface technology.Currently, more than 80 patents have been obtained.Its product line includes the OB series of brain-computer interfaces, the OHand™ series of intelligent bionic hands, and the ORF series of neurorehabilitation exoskeletons, among others. Since its launch in 2020, the OHand™ intelligent bionic hand has quickly captured market share from imported brands with its cutting-edge technology and exceptional cost-performance ratio. In 2023, the OHand™ bionic hand successively obtained FDA/CE certifications and, last year, received the U.S. PDAC commercial insurance payment code. It has taken the lead in overseas commercialization across many countries and regions worldwide, including the United States, the Middle East, Russia, Ukraine, and India. OYMotion's bionic hand has become a hallmark of Chinese innovation.

OYMotion Founder Hua Liang NiIndicates,Thanks to the trust and continuous support of both new and existing shareholders, the rapid completion of two rounds of financing in just a few months is not only an endorsement from the shareholders but also a testament to the company's robust growth potential. After the completion of this round of financing, the OYMotion team will adopt a more open attitude to deepen cooperation with industry partners, jointly promoting the industrialization process of brain science and the robotics industry, and striving forward towards becoming a leading global technology enterprise.